Consensus on biomarker utility for ACTH-dependent Cushing syndrome: a Pituitary Society Modified Delphi Panel
The Journal of Clinical Endocrinology & Metabolism · 16.07.2026
DOI: 10.1210/clinem/dgag279 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 16.07.2026. Verfasst von Maria Fleseriu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Health & Science University, Portland, OR, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Crinetics Pharmaceuticals, Inc., Good Publication Practice.
Abstract (Originalsprache)
Context
Biochemical test results are central to clinical decision-making for the diagnosis and management of Cushing syndrome (CS). With emerging research and increasing availability of different tests, updated consensus on the utility of these biomarkers is warranted.
Objective
To establish an updated consensus on the role of biomarkers in the diagnosis and monitoring of adrenocorticotropic hormone-dependent CS, address novel therapeutic approaches, and identify areas for future research.
Design
A modified 2-round Delphi panel was conducted. Consensus was defined as ≥70% agreement/disagreement for Likert-scale statements or ≥70% selection of the same option for single-choice questions.
Setting
Participants represented a range of international expertise.
Participants
Forty-one participants took part in the Delphi panel, with no attrition between rounds (one nonclinician was not required to complete the second round). An 8-member Steering Committee guided statement development.
Results
Of statements designed to reach consensus, 45% (14/31) and 44% (11/25) statements reached consensus in Rounds 1 and 2, respectively. Notably, most panelists reported the use of late-night salivary cortisol for diagnosis of mild CS and for monitoring following pituitary surgery or medical or radiation therapy. Most panelists responded that block-and-replace therapies can be considered in patients with cyclical or severe CS, and consensus was reached that restoration of circadian rhythm is a treatment goal for patients with CS.
Conclusion
Areas of alignment among experts on the diagnosis and monitoring of CS are presented. The findings from this study are intended to support clinicians in their clinical decision-making and highlight priority areas for future research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oregon Health & Science University, Portland, OR, USA.
- Massachusetts General Hospital, Boston, MA, USA.
- Mayo Clinic, Rochester, MN, USA.
- Kobe University Hospital, Kobe, Japan.
- Department of Medicine IV, LMU University Hospital, Ludwig-Maximilians-Universität, München, Munich, Germany.
- School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
ORCID-Profile: Maria Fleseriu, Beverly Mk Biller, Irina Bancos, Hidenori Fukuoka, Martin Reincke, John Newell-Price, Shlomo Melmed
Förderung
- Crinetics Pharmaceuticals, Inc.
- Good Publication Practice
Zitieren
APA
Fleseriu, M., Biller, B. M., Bancos, I., Fukuoka, H., Reincke, M., Newell-Price, J., Melmed, S., & the Pituitary Society International Cushing Syndrome Delphi Panel Consensus Group (2026). Consensus on biomarker utility for ACTH-dependent Cushing syndrome: a Pituitary Society Modified Delphi Panel. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag279
Vancouver
Fleseriu M, Biller BM, Bancos I, Fukuoka H, Reincke M, Newell-Price J, et al. Consensus on biomarker utility for ACTH-dependent Cushing syndrome: a Pituitary Society Modified Delphi Panel. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag279
BibTeX
@article{Fleseriu2026,
author = {Fleseriu, Maria and Biller, Beverly Mk and Bancos, Irina and Fukuoka, Hidenori and Reincke, Martin and Newell-Price, John and Melmed, Shlomo and the Pituitary Society International Cushing Syndrome Delphi Panel Consensus Group, the Pituitary Society International Cushing Syndrome Delphi Panel Consensus Group},
title = {Consensus on biomarker utility for ACTH-dependent Cushing syndrome: a Pituitary Society Modified Delphi Panel},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag279}
}
EUVIMED